Both in Pharmaceuticals
Silo Pharma vs Matinas BioPharma Holdings
Over the past year SILO returned −85.4% and MTNB returned −91.0%; their daily moves had a correlation of -0.02.
SILO −85.4% MTNB −91.0%Growth of $1, one year, split-adjusted
| Metric | SILO | MTNB |
|---|---|---|
| Price | $1.51 | $2.55 |
| Market cap | $2.6M | $2.5M |
| Today | −6.21% | −11.46% |
| 1 month | −39.1% | −14.0% |
| 6 months | −72.0% | −66.0% |
| Year to date | −70.4% | −71.0% |
| 1 year | −86.6% | −91.1% |
| Revenue growth (YoY) | −100.0% | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 49.0× | — |
| Net cash | $5.2M | $755.0K |
| Dividend yield | — | — |
| Volatility (60d) | 104.5% | 781.4% |
| Short % of float | 2.8% | 4.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).